This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Products


AVAXIM® (hepatitis A vaccine (inactivated, adsorbed))
Avaxim®
Avaxim® Junior (hepatitis A vaccine (inactivated, adsorbed))
Avaxim® Junior
Cerezyme® (imiglucerase for injection)
Cerezyme®
Clexane (enoxaparin)
Clexane®
Lantus® (insulin glargine 100 units/mL)
Lantus®
Lemtrada® (alemtuzumab)
Lemtrada®
GB only content
MenQuadfiTM▼  (meningococcal (group A,C,W,Y) conjugate vaccine)
MenQuadfiTM▼ 
Myozyme® (alglucosidase alfa)
Myozyme®
GB only content
Nexviadyme Logo
Nexviadyme®
Quadrivalent Influenza Vaccine (split virion, inactivated)
Quadrivalent Influenza Vaccine
Quadrivalent Influenza Vaccine▼
Repevax® (diphtheria, tetanus, pertussis and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
Repevax®
Revaxis® diphtheria, tetanus & poliomyelitis (inactivated) vaccine (absorbed, reduced antigen(s) content)
Revaxis® 
GB only content
Sarclisa Logo
SARCLISA®
Stamaril® (yellow fever vaccine (live))
Stamaril®
GB only content
Supemtek▼ (quadrivalent Influenza Vaccine (recombinant, prepared in cell culture))
Supemtek▼
Toujeo® (insulin glargine 300 units/ml)
Toujeo®
Typhim Vi® (typhoid polysaccharide vaccine)
Typhim Vi®
GB only content
Vaxelis®
Viatim®

MAT-XU-2305047 (v1.0) - Date of preparation: November 2023